BridgeBio Pharma Inc
NASDAQ:BBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
D-Box Technologies Inc
TSX:DBO
|
CA |
|
R
|
Renovaro Biosciences Inc
NASDAQ:RENB
|
US |
|
Applied Therapeutics Inc
NASDAQ:APLT
|
US |
|
U-Next Holdings Co Ltd
OTC:USNNF
|
JP |
Shareholder Yield
Current shareholder yield for BBIO is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BBIO Price
BridgeBio Pharma Inc
| Average Annual Return | 75.84% |
| Standard Deviation of Annual Returns | 259.47% |
| Max Drawdown | -92% |
| Market Capitalization | 13.2B USD |
| Shares Outstanding | 195 860 000 |
| Percentage of Shares Shorted | 13.77% |
